0001214659-18-007681.txt : 20181213
0001214659-18-007681.hdr.sgml : 20181213
20181213185732
ACCESSION NUMBER: 0001214659-18-007681
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181206
FILED AS OF DATE: 20181213
DATE AS OF CHANGE: 20181213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Martinez Maria E
CENTRAL INDEX KEY: 0001761768
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 181234281
MAIL ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: STE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
marketforms-43510.xml
PRIMARY DOCUMENT
X0306
4
2018-12-06
0001576263
Mirati Therapeutics, Inc.
MRTX
0001761768
Martinez Maria E
C/O MIRATI THERAPEUTICS, INC.
9393 TOWNE CENTRE DRIVE, STE 200
SAN DIEGO
CA
92121
true
false
false
false
Non Qualified Stock Option (right to buy)
39.76
2018-12-06
4
A
false
25000
0
A
2028-12-05
Common Stock
25000
25000
D
The shares subject to the Option vest and become exercisable in 36 equal monthly installments following the date of grant.
/s/ Vickie Reed, Attorney-in-Fact
2018-12-13